- Home
- BE vs WAT Comparison
BE vs WAT Comparison
Compare BE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BE
- WAT
- Stock Information
- Founded
- BE 2001
- WAT 1958
- Country
- BE United States
- WAT United States
- Employees
- BE N/A
- WAT N/A
- Industry
- BE Industrial Machinery/Components
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- BE Energy
- WAT Industrials
- Exchange
- BE Nasdaq
- WAT Nasdaq
- Market Cap
- BE 16.5B
- WAT 17.4B
- IPO Year
- BE 2018
- WAT 1995
- Fundamental
- Price
- BE $87.84
- WAT $327.88
- Analyst Decision
- BE Buy
- WAT Buy
- Analyst Count
- BE 20
- WAT 14
- Target Price
- BE $52.23
- WAT $376.57
- AVG Volume (30 Days)
- BE 15.4M
- WAT 688.1K
- Earning Date
- BE 11-06-2025
- WAT 11-04-2025
- Dividend Yield
- BE N/A
- WAT N/A
- EPS Growth
- BE N/A
- WAT 10.77
- EPS
- BE 0.10
- WAT 11.09
- Revenue
- BE $1,630,054,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- BE $23.08
- WAT $7.15
- Revenue Next Year
- BE $23.54
- WAT $6.34
- P/E Ratio
- BE $851.21
- WAT $29.56
- Revenue Growth
- BE 22.72
- WAT 5.89
- 52 Week Low
- BE $9.02
- WAT $275.05
- 52 Week High
- BE $95.70
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- BE 67.93
- WAT 59.89
- Support Level
- BE $83.47
- WAT $319.34
- Resistance Level
- BE $95.70
- WAT $331.28
- Average True Range (ATR)
- BE 7.15
- WAT 8.73
- MACD
- BE -0.06
- WAT 2.77
- Stochastic Oscillator
- BE 77.96
- WAT 74.94
About BE Bloom Energy Corporation
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. Bloom primarily sells its systems in the United States and internationally.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.